Recombinant Expression of theβ-Subunit of HLA-DR10 for the Selection of Novel Lymphoma Targeting Molecules-Reference-Cited by-同舟云学术

Recombinant Expression of theβ-Subunit of HLA-DR10 for the Selection of Novel Lymphoma Targeting Molecules

Published:2007-08 Issue:4 Volume:22 Page:531-542
ISSN:1084-9785
Container-title:Cancer Biotherapy and Radiopharmaceuticals
language:en
Short-container-title:Cancer Biotherapy and Radiopharmaceuticals

Author:

Albrecht Huguette¹,Cosman Monique²,Ngu-Schwemlein Maria³,Corzett Michele²,Curran Kena W.⁴,Dolan Cheryl²,Fang Xiangming⁴,DeNardo Sally J.¹,DeNardo Gerald L.¹,Balhorn Rod²

Affiliation:

1. Cancer Center, University of California, Davis Medical Center, Sacramento, CA

2. Chemistry, Material, and Life Sciences, Lawrence Livermore National Laboratory, Livermore, CA

3. Chemistry Department, Winston-Salem State University, Winston-Salem, NC

4. Genway Biotech, Inc., San Diego, CA

Publisher

Mary Ann Liebert Inc

Subject

Cancer Research,Pharmacology,Radiology, Nuclear Medicine and imaging,Oncology,General Medicine,Cancer Research,Pharmacology,Radiology, Nuclear Medicine and imaging,Oncology,General Medicine

Link

http://www.liebertpub.com/doi/pdf/10.1089/cbr.2007.375A

Reference26 articles.

1. The HLA System

2. The 1995 Albert Lasker Medical Research Award. The class I and class II proteins of the human major histocompatibility complex

3. Lymphoma-selective antibody Lym-1 recognizes a discontinuous epitope on the light chain of HLA-DR10

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nanomolecular HLA-DR10 Antibody Mimics: A Potent System for Molecular Targeted Therapy and Imaging;Cancer Biotherapy and Radiopharmaceuticals;2008-12

2. Survey of the year 2007 commercial optical biosensor literature;Journal of Molecular Recognition;2008-11